Chemo Pharma Laboratories Ltd

BSE :506365 NSE :- Sector : Pharmac..
70.74
Change: 0.00(0.00%)
No Graph Available
52 week Low
52.25
52 week High
154.00
Day low
70.74
Day high
72
Prev Close
70.74
Open
70.74
6M return
5.14%
1Y return
-5.83%
MCap(Rs. in Cr.)
10.61
Total Volume
108
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Chemo Pharma Lab
70.74
Change: 0.00 (0.00%)
1 Year return
-5.83%
Risk (Std Dev)
0.19%
PE Ratio
27.21
MCap( in Cr.)
10.61
Shukra Pharma.
205.60
Change: 3.05 (1.51%)
1 Year return
319.08%
Risk (Std Dev)
0.48%
PE Ratio
109.95
MCap( in Cr.)
900.28
Oxygenta Pharma
82.56
Change: -1.68 (-1.99%)
1 Year return
159.46%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
305.34
Everest Organics
243.65
Change: -12.80 (-4.99%)
1 Year return
78.89%
Risk (Std Dev)
0.35%
PE Ratio
NM
MCap( in Cr.)
249.03
Pharmaids Pharma
61.94
Change: 0.00 (0.00%)
1 Year return
19.83%
Risk (Std Dev)
0.16%
PE Ratio
NM
MCap( in Cr.)
218.45
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Chemo Pharma Laboratories reports standalone net loss of Rs 0.17 crore in the December 2024 quarter

Net loss of Chemo Pharma Laboratories reported to Rs 0.17 crore in the quarter ended December 2024 as against net profit of Rs 0.68 crore during the p....

27 Jan 2025 17:42

Chemo Pharma Laboratories to table results

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 27 January 2025.Powered by Capital Market - Liv....

15 Jan 2025 10:12

Chemo Pharma Laboratories standalone net profit rises 38.64% in the September 2024 quarter

Net profit of Chemo Pharma Laboratories rose 38.64% to Rs 0.61 crore in the quarter ended September 2024 as against Rs 0.44 crore during the previous ....

29 Oct 2024 07:32

Chemo Pharma Laboratories to announce Quarterly Result

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Liv....

17 Oct 2024 10:35

Chemo Pharma Laboratories AGM scheduled

Chemo Pharma Laboratories announced that the 82th Annual General Meeting (AGM) of the company will be held on 23 September 2024.Powered by</i....

30 Jul 2024 17:11

Chemo Pharma Laboratories standalone net profit declines 34.21% in the June 2024 quarter

Net profit of Chemo Pharma Laboratories declined 34.21% to Rs 0.25 crore in the quarter ended June 2024 as against Rs 0.38 crore during the previous q....

30 Jul 2024 07:33

View More
Subscribe for our
newsletter
Open Account Now